kynurenic acid and thiazoles

kynurenic acid has been researched along with thiazoles in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (6.25)18.2507
2000's10 (62.50)29.6817
2010's5 (31.25)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cesura, AM; Huguenin, P; Kettler, R; Röver, S; Szente, A1
Obrenovitch, TP; Urenjak, J2
Ballerini, C; Chiarugi, A; Cozzi, A; Massacesi, L; Moroni, F1
Carpenedo, R; Meli, E; Moroni, F; Pellegrini-Giampietro, DE; Peruginelli, F1
Engberg, G; Erhardt, C; Erhardt, S; Schwieler, L1
Barger, SW; Jiang, S; Sims, TJ; Wu, SZ1
Carpendo, R; Cipriani, G; Cozzi, A; Izzo, E; Moroni, F; Veneroni, O1
Bédard, PJ; Grégoire, L; Guidetti, P; Izzo, E; Rassoulpour, A; Samadi, P; Schwarcz, R1
Bédard, PJ; Di Paolo, T; Grégoire, L; Guidetti, P; Izzo, E; Rassoulpour, A; Samadi, P; Schwarcz, R1
Ball, HJ; Hunt, NH; Mellor, AL; Miu, J1
Adame, A; Andrews-Zwilling, Y; Flik, G; Giorgini, F; Guidetti, P; Hsieh, EW; Huang, SY; Huang, Y; Laue, G; Lee, J; Louie, JY; Masliah, E; Moussaoui, S; Muchowski, JM; Muchowski, PJ; Notarangelo, FM; Patrick, C; Rassoulpour, A; Sathyasaikumar, KV; Scearce-Levie, K; Schwarcz, R; Truong, J; Wu, HQ; Wu, T; Zwilling, D1
Barnes, C; Bergman, J; Ferré, S; Fratta, W; Goldberg, SR; Justinova, Z; Kangas, BD; Mascia, P; Panlilio, LV; Parashos, A; Pistis, M; Redhi, GH; Scherma, M; Schwarcz, R; Secci, ME; Solinas, M; Tanda, G; Wu, HQ; Zara, T1
Abarca, J; Ferrada, C; Gysling, K; Sotomayor-Zárate, R1
Auber, A; Goldberg, SR; Justinova, Z; Panlilio, LV; Redhi, GH; Schindler, CW; Schwarcz, R; Secci, ME; Thorndike, EB1
Beggiato, S; Borelli, AC; Bradberry, CW; Ferraro, L; Ferré, S; Goldberg, SR; Justinova, Z; Mascia, P; Melis, M; Panlilio, LV; Pistis, M; Sagheddu, C; Schindler, CW; Schwarcz, R; Secci, ME; Tanda, G; Tomasini, MC1

Other Studies

16 other study(ies) available for kynurenic acid and thiazoles

ArticleYear
Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase.
    Journal of medicinal chemistry, 1997, Dec-19, Volume: 40, Issue:26

    Topics: Animals; Brain; Enzyme Inhibitors; Extracellular Space; Gerbillinae; Kidney; Kinetics; Kynurenic Acid; Kynurenine 3-Monooxygenase; Liver; Mitochondria; Mixed Function Oxygenases; Molecular Structure; Neuroprotective Agents; Rats; Structure-Activity Relationship; Sulfonamides; Thiazoles

1997
In vivo assessment of kynurenate neuroprotective potency and quinolinate excitotoxicity.
    Amino acids, 2000, Volume: 19, Issue:1

    Topics: Animals; Enzyme Inhibitors; Frontal Lobe; Kynurenic Acid; Male; Neuroprotective Agents; Quinolinic Acid; Rats; Sulfonamides; Thiazoles

2000
Kynurenine 3-hydroxylase inhibition in rats: effects on extracellular kynurenic acid concentration and N-methyl-D-aspartate-induced depolarisation in the striatum.
    Journal of neurochemistry, 2000, Volume: 75, Issue:6

    Topics: Administration, Oral; Animals; Cerebral Cortex; Corpus Striatum; Electroencephalography; Enzyme Inhibitors; Extracellular Space; Injections, Intraperitoneal; Kynurenic Acid; Kynurenine 3-Monooxygenase; Male; Membrane Potentials; Microdialysis; Mixed Function Oxygenases; N-Methylaspartate; Neuroprotective Agents; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Sulfonamides; Thiazoles

2000
Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis.
    Neuroscience, 2001, Volume: 102, Issue:3

    Topics: Animals; Astrocytes; Brain; Cytoplasmic Granules; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Immunohistochemistry; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Mixed Function Oxygenases; Multiple Sclerosis; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Spinal Cord; Sulfonamides; Thiazoles

2001
Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.
    Journal of neurochemistry, 2002, Volume: 82, Issue:6

    Topics: Alanine; Animals; Brain Ischemia; Cell Death; Cell Hypoxia; Culture Media, Conditioned; Enzyme Inhibitors; Glucose; Hippocampus; In Vitro Techniques; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Mixed Function Oxygenases; Neurons; Neuroprotective Agents; Pyramidal Cells; Quinolinic Acid; Rats; Sulfonamides; Thiazoles

2002
Prostaglandin-mediated control of rat brain kynurenic acid synthesis--opposite actions by COX-1 and COX-2 isoforms.
    Journal of neural transmission (Vienna, Austria : 1996), 2005, Volume: 112, Issue:7

    Topics: Animals; Brain; Diclofenac; Enzyme Inhibitors; Indomethacin; Isoxazoles; Kynurenic Acid; Male; Meloxicam; Prostaglandins; Protein Isoforms; Rats; Rats, Sprague-Dawley; Thiazines; Thiazoles

2005
Schwann cells exhibit excitotoxicity consistent with release of NMDA receptor agonists.
    Journal of neuroscience research, 2005, Mar-01, Volume: 79, Issue:5

    Topics: 2-Amino-5-phosphonovalerate; Analysis of Variance; Animals; Calcium; Cell Death; Cells, Cultured; Culture Media, Conditioned; D-Amino-Acid Oxidase; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Excitatory Amino Acid Antagonists; Fluorescent Antibody Technique; Glutamic Acid; Hippocampus; Kynurenic Acid; Microtubule-Associated Proteins; Nerve Degeneration; Neurons; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schwann Cells; Tetrazolium Salts; Thiazoles; Time Factors

2005
Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus.
    Neuropharmacology, 2005, Volume: 48, Issue:6

    Topics: Animals; Avoidance Learning; Basal Ganglia; Behavior, Animal; Brain Chemistry; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Interactions; Extracellular Space; Glutamic Acid; Kynurenic Acid; Kynurenine 3-Monooxygenase; Male; Microdialysis; Mixed Function Oxygenases; omega-Conotoxin GVIA; Potassium Chloride; Rats; Rats, Wistar; Statistics, Nonparametric; Sulfonamides; Thiazoles; Time Factors

2005
Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in Parkinsonian monkeys.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:7

    Topics: Analysis of Variance; Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Kynurenic Acid; Kynurenine 3-Monooxygenase; Levodopa; Macaca fascicularis; Mixed Function Oxygenases; Motor Activity; Parkinsonian Disorders; Quinolinic Acid; Sulfonamides; Thiazoles; Time Factors

2005
Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.
    Behavioural brain research, 2008, Jan-25, Volume: 186, Issue:2

    Topics: Animals; Antiparkinson Agents; Behavior, Animal; Disease Models, Animal; Drug Interactions; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Levodopa; Macaca fascicularis; Motor Activity; Parkinsonian Disorders; Quinolinic Acid; Sulfonamides; Thiazoles; Time Factors

2008
Effect of indoleamine dioxygenase-1 deficiency and kynurenine pathway inhibition on murine cerebral malaria.
    International journal for parasitology, 2009, Volume: 39, Issue:3

    Topics: Animals; Brain; Enzyme Inhibitors; Female; Gas Chromatography-Mass Spectrometry; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase; Malaria, Cerebral; Metabolic Networks and Pathways; Mice; Mice, Inbred C57BL; Picolinic Acids; Quinolinic Acid; RNA, Messenger; Sulfonamides; Thiazoles; Tryptophan Oxygenase

2009
Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration.
    Cell, 2011, Jun-10, Volume: 145, Issue:6

    Topics: Administration, Oral; Alzheimer Disease; Animals; Brain Chemistry; Disease Models, Animal; Female; Humans; Huntington Disease; Kynurenic Acid; Kynurenine 3-Monooxygenase; Male; Mice; Mice, Transgenic; Sulfonamides; Thiazoles

2011
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid.
    Nature neuroscience, 2013, Volume: 16, Issue:11

    Topics: Analgesics; Animals; Benzoxazines; Brain; Cannabinoid Receptor Agonists; Conditioning, Operant; Cues; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug-Seeking Behavior; Kynurenic Acid; Male; Memory, Short-Term; Morpholines; Naphthalenes; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Reinforcement, Psychology; Saimiri; Secondary Prevention; Self Administration; Substance-Related Disorders; Sulfonamides; Thiazoles; Time Factors; Wakefulness

2013
The activation of metabotropic glutamate 5 receptors in the rat ventral tegmental area increases dopamine extracellular levels.
    Neuroreport, 2017, Jan-01, Volume: 28, Issue:1

    Topics: Animals; Dopamine; Excitatory Amino Acid Agents; Extracellular Fluid; Glutamic Acid; Glycine; Kynurenic Acid; Male; Microdialysis; Phenylacetates; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Thiazoles; Ventral Tegmental Area

2017
Attenuating Nicotine Reinforcement and Relapse by Enhancing Endogenous Brain Levels of Kynurenic Acid in Rats and Squirrel Monkeys.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017, Volume: 42, Issue:8

    Topics: Animals; Cocaine; Dopamine; Isoxazoles; Kynurenic Acid; Male; Nicotine; Nucleus Accumbens; Phenylurea Compounds; Rats; Recurrence; Reinforcement, Psychology; Saimiri; Secondary Prevention; Self Administration; Sulfonamides; Thiazoles

2017
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ
    Molecular neurobiology, 2019, Volume: 56, Issue:5

    Topics: Action Potentials; alpha7 Nicotinic Acetylcholine Receptor; Animals; Astrocytes; Brain; Cells, Cultured; Dronabinol; Glutamic Acid; Kynurenic Acid; Male; Nucleus Accumbens; Prefrontal Cortex; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reward; Rimonabant; RNA, Messenger; Sulfonamides; Thiazoles; Ventral Tegmental Area

2019